Riverview Trust Company’s Chemed CHE Stock Holding History

Riverview Trust Company’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1	Closed	-$530	–	639
2024 Q4	$530	Buy	+1	New	+$564	﹤0.01%	782

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Riverview Trust Company's CHE Position: Q1 2025 in Review

Riverview Trust Company sold out of Chemed (CHE) in Q1 2025, closing a stake of 1 share — an estimated $530 sold.

Riverview Trust Company first reported a position in CHE in Q4 2024 and held it in 1 quarter. The position peaked at $530 in Q4 2024. 553 funds tracked by Wall St. Rank hold CHE as of Q1 2025.

Riverview Trust Company reported no remaining Chemed position as of Q1 2025 after selling out during the quarter.
Riverview Trust Company sold 1 Chemed share in Q1 2025, an estimated $530.
Riverview Trust Company first reported a position in Chemed in Q4 2024 and held it in 1 quarter.
Riverview Trust Company's Chemed position peaked at $530 in Q4 2024.
553 funds tracked by Wall St. Rank held Chemed as of Q1 2025.

Based on Riverview Trust Company's 13F filing for Q1 2025, filed 11 Apr 2025.